Now More Than Ever, We Need to Focus on Clinical Trial Participation : Oncology Times
An abstract is unavailable.
Related Articles
Homepage of Mark Cuban Cost Plus Drugs
Mark Cuban Cost Plus Drug homepage. Provides safe, affordable medicine or medication with transparent low prices.
Homepage of Mark Cuban Cost Plus Drugs
Mark Cuban Cost Plus Drug homepage. Provides safe, affordable medicine or medication with transparent low prices.
#YellowFever – Healthcare Social Media Analytics and Transcripts
Yellow Fever is an acute viral hemorrhagic disease that is spread by the bite of mosquitoes. Early stage symptoms may include headache, muscle and joint
Protecting Travelers Against Yellow Fever in a Time of Vaccine Shortages
This Viewpoint examines strategies for vaccinating travelers against yellow fever given recent vaccine shortages and global yellow fever outbreaks.
Yellow Fever — Once Again on the Radar Screen in the Americas | NEJM
Sylvatic transmission cycles of yellow fever continue to occur in endemic tropical regions. If the outbreak in Brazil leads to urban spread, U.S. clinicians should…
Not So BenignAntiphospholipid Antibody Syndrome: Clots, Complement, and Catastrophe!
Antiphospholipid syndrome (APS) is a thromboinflammatory disorder characterized by thrombosis and/or recurrent fetal loss accompanied by persistently positive t
Paper: Proteomic Profiling of Different Antiphospholipid Antibody-Positive Phenotypes: Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry
Program: Oral and Poster Abstracts Session: 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster II Hematology Disease Topics & Pathways: Research, Bleeding and…
#18ICML – 18th International Conference on Malignant Lymphoma – Social Media Analytics and Transcripts
The conference objectives and learning outcomes are: Acquaintance with the latest advances in basic science regarding lymphoma; Learning about the latest
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis | NEJM
Osteoporosis is a common complication of long-term glucocorticoid therapy for which there is no well-proved preventive or restorative treatment. We carried out two 48-week, randomized,…
Program Guide – ASCO Meeting Program Guide
Sabin Goktas Aydin SBU Kanuni Sultan Süleyman Education and Research Hospital, Istanbul, Turkey Sabin Goktas Aydin, Burcin Demirel, Ozden Demir, Ayberk Bayramgil, Ozlem Kutlu, Cigdem…